Elkhorn Partners’s Cardiovascular Systems, Inc. CSII Stock Holding History

Elkhorn Partners’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-9,300	Closed	-$221K	–	43
2016 Q3	$221K	Sell	9,300 -3,700	-28%	-$81K	0.13%	36
2016 Q2	$239K	Sell	13,000 -5,000	-28%	-$78.1K	0.16%	37
2016 Q1	$187K	Buy	18,000 +2,000	+13%	+$20.3K	0.11%	40
2015 Q4	$242K	Sell	16,000 -2,700	-14%	-$40.1K	0.14%	38
2015 Q3	$296K	Buy	+18,700	New	+$471K	0.18%	33

Other funds holding CSII

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Elkhorn Partners's CSII Position: Q4 2016 in Review

Elkhorn Partners sold out of Cardiovascular Systems, Inc. (CSII) in Q4 2016, closing a stake of 9,300 shares — an estimated $221K sold.

Elkhorn Partners first reported a position in CSII in Q3 2015 and held it in 5 quarters. The position peaked at $296K in Q3 2015. 142 funds tracked by Wall St. Rank hold CSII as of Q4 2016.

Elkhorn Partners reported no remaining Cardiovascular Systems, Inc. position as of Q4 2016 after selling out during the quarter.
Elkhorn Partners sold 9,300 Cardiovascular Systems, Inc. shares in Q4 2016, an estimated $221K.
Elkhorn Partners first reported a position in Cardiovascular Systems, Inc. in Q3 2015 and held it in 5 quarters.
Elkhorn Partners's Cardiovascular Systems, Inc. position peaked at $296K in Q3 2015.
142 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q4 2016.

Based on Elkhorn Partners's 13F filing for Q4 2016, filed 13 Feb 2017.